I was recently diagnosed with anti-NMDA receptor encephalitis
Open-source developer BurntSushi shares his terrifying journey through anti-NMDA receptor encephalitis, an autoimmune disease that mimicked severe psychiatric illness, leading to misdiagnosis and hospitalization. His candid account highlights the critical role of medical advocacy and sheer luck in navigating a complex healthcare system to receive a life-saving diagnosis. This deeply personal story resonates with HN readers, sparking widespread discussion on medical misdiagnosis, the challenges of modern healthcare, and the fragility of health.
The Lowdown
Andrew Gallant, known as 'BurntSushi' in the open-source community, recounts his harrowing experience with anti-NMDA receptor encephalitis, a rare autoimmune disorder. His blog post details the onset of severe physical and psychological symptoms that rapidly escalated from flu-like discomfort and anxiety to profound psychosis and suicidal ideation.
- Initial Symptoms & Misdiagnosis: The ordeal began with non-specific flu-like symptoms, quickly progressing to crippling anxiety, balance issues, jaw pain, and terrifying psychological symptoms including delusions and auditory hallucinations. This led to an initial diagnosis of generalized anxiety disorder and subsequent hospitalization in a psychiatric facility after a fall.
- Healthcare System Challenges: Despite his wife's efforts, the psychiatric hospital initially resisted transferring him for neurological evaluation, believing he had been 'medically cleared'. His escape from this diagnostic trap was facilitated by a fortunate connection: a neighbor who was friends with a neurosurgeon, leading to his transfer to Brigham and Women's Hospital.
- Diagnosis & Treatment: At Brigham and Women's, he received intravenous immunoglobulin (IVIG) and steroids, even before a definitive diagnosis. An MRI revealed a brain lesion, and the official diagnosis of anti-NMDA receptor encephalitis was confirmed weeks later via a cerebral spinal fluid antibody test.
- Recovery & Outlook: Gallant is now recovering, tapering off medications, and participating in a clinical trial for satralizumab. He emphasizes the good prognosis for this condition when caught early and expresses immense gratitude to his wife, his employer, and his medical team.
His account serves as a powerful testament to the importance of perseverance in the face of medical ambiguity, the critical support network of loved ones, and the unpredictable nature of autoimmune diseases that can masquerade as severe mental illness.
The Gossip
Misdiagnosis Mayhem
Many commenters shared their own or their loved ones' agonizing experiences with misdiagnosis, often involving autoimmune conditions or the dismissal of physical symptoms as psychological. Themes included doctors telling patients 'it's all in your head,' years of suffering before a correct diagnosis, and the critical role of self-advocacy or sheer luck in getting proper care. The anecdotes highlighted systemic issues where complex or rare conditions are overlooked.
Healthcare Hurdles
The discussion often pivoted to broader critiques of the healthcare system, particularly the initial psychiatric hospitalization and the difficulty in securing neurological evaluation. Commenters debated the balance between preventing hypochondria and ensuring patients with real, undiagnosed conditions are not dismissed. The author himself detailed how a 'lucky connection' was crucial in escaping the psychiatric ward, sparking outrage and reinforcing the idea that access to adequate care can be arbitrary.
Open Source Ovation
Andrew Gallant's reputation as 'BurntSushi,' a prolific open-source developer, featured prominently, with many users expressing admiration for his work on tools like ripgrep and nfldb. Commenters wished him well, thanked him for his contributions, and noted their surprise and respect for his continued output even during his illness. Some inquired about ways to support him, illustrating the strong community bond within Hacker News.
Biological Brain-Twisters
The technical and medical aspects of anti-NMDA receptor encephalitis, and related conditions, generated significant interest. Commenters noted the recent discovery of the disease (2007) and the broader need for biomedical research. Discussions also touched upon the connection to ovarian tumors (though not present in the author's case), the mechanism of NMDA receptor antagonism, and the role of monoclonal antibody treatments, reflecting HN's typical engagement with scientific and technical details.